Cargando…
Anti-HER2 scFv-CCL19-IL7 recombinant protein inhibited gastric tumor growth in vivo
HER-2 targeted therapies, such as monoclonal antibodies (mAbs) and CAR-T cell therapy have been applied in the treatment of various of cancers. However, the anti-HER2 CAR-T cell therapy are limited by its expensive production procedure and fatal side effects such as cytokine storm or “On target, off...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213520/ https://www.ncbi.nlm.nih.gov/pubmed/35729189 http://dx.doi.org/10.1038/s41598-022-14336-1 |